1906. Priming History and Risk of H3N2 Vaccine Failure Among Young Children
Session: Poster Abstract Session: Vaccines: Influenza
Saturday, October 10, 2015
Room: Poster Hall
Posters
  • McLean_IDWeek_poster_1906.pdf (267.6 kB)
  • Background: Each season, the US ACIP considers prior vaccination history and vaccine strain changes when recommending the number of influenza vaccine doses needed for children aged 6 months – 8 years to be considered adequately vaccinated. However, data supporting the recommendations are limited. We used vaccinated enrollments from four seasons to examine priming history and risk of infection in young children. 

    Methods: Children aged 18 months – 8 years with medically attended acute respiratory illness were recruited during 2007-08, 2010-11, 2011-12, and 2012-13 influenza seasons. Influenza status was determined by RT-PCR. Influenza vaccination dates since birth were obtained from a validated vaccine registry. Logistic regression models adjusted for age, season, and calendar time were used to assess the association between priming history and risk of A/H3N2 influenza. We used separate models for priming history based on total doses received (0, 1, ≥2) and antigenically similar H3 doses received (0, 1, ≥2). Children who received zero or two doses during the current season or live attenuated vaccine in any season were excluded. 

    Results: A total of 609 vaccinated children were included; 91 (15%) had influenza H3N2. Children received a median of 1 antigenically similar dose [interquartile range (IQR): 0, 2] and 3 total doses (IQR: 2, 4) in the past. 480 (24%) received antigenically similar H3 only, 207 (34%) received antigenically distinct H3 only, 219 (36%) received both antigenically similar and distinct H3, and 35 (6%) had not received any influenza vaccine in the past. There were no differences in risk of H3 influenza by total doses (any antigenic group) received [odd ratio, OR (95% confidence interval, CI): 1.9 (0.4, 8.7) and 1.4 (0.4, 4.3) for 1 and ≥2 doses compared to 0 doses, respectively].  The number of antigenically similar doses received also did not influence risk of vaccine failure [OR (95% CI): 1.8 (0.8, 4.1) and 1.3 (0.5, 3.4) for 1 and ≥2 doses compared to 0 doses, respectively].  

    Conclusion: Risk of A/H3N2 vaccine failure among young children vaccinated with inactivated influenza vaccine did not differ with regard to priming history. Further studies should examine the importance of priming history for H1 and B influenza to inform vaccine policy.

    Huong Mclean, PhD, Jennifer King, MPH and Edward Belongia, MD, Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Foundation, Marshfield, WI

    Disclosures:

    H. Mclean, MedImmune: Investigator , Research support

    J. King, None

    E. Belongia, Medimmune: Investigator , Research support

    See more of: Vaccines: Influenza
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.